Jinarc 45 mg (Tolvaptan TABLET) 45 MG

JINARC 45 MG tablets contain tolvaptan, a medication used to manage fluid balance in certain conditions. This oral tablet is designed to help the body excrete excess water, aiding in symptom relief.

Strength

45 MG

Pack Size

7/14/30

Manufacturer / TM Owner

OTSUKA PHARMACEUTICAL CO LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

JINARC 45 MG tablets are primarily used to manage fluid retention in conditions where the body retains too much water. Tolvaptan works by blocking a hormone that regulates water balance, helping the kidneys remove excess fluid. This can be beneficial for individuals experiencing symptoms related to fluid overload, such as swelling or discomfort.

Side Effects

Common effects of JINARC 45 MG tablets may include increased urination, which is the intended action to remove excess fluid from the body. Some individuals may also experience dry mouth or thirst as the body adjusts to the medication. These effects are generally mild and temporary.

Precautions & Warnings

JINARC 45 MG tablets should be handled with care, especially for individuals with certain medical conditions. It is important to follow the advice of a healthcare professional regarding the use of this medication. Always store the tablets in a cool, dry place away from direct sunlight.

Avoid Interactions

JINARC 45 MG tablets may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

JINARC 45 MG tablets are used to manage fluid retention in conditions where the body retains too much water, helping to relieve symptoms like swelling.

Tolvaptan works by blocking a hormone that regulates water balance, helping the kidneys remove excess fluid from the body.

Common effects include increased urination, dry mouth, and thirst, which are generally mild and temporary.

It is important to consult a healthcare professional before taking JINARC 45 MG with other medications to avoid potential interactions.

Store JINARC 45 MG tablets in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.